BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 16386326)

  • 1. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic medicines: Greek physicians' perceptions and prescribing practices.
    Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
    J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions.
    Balasopoulos T; Charonis A; Athanasakis K; Kyriopoulos J; Pavi E
    Health Policy; 2017 Mar; 121(3):265-272. PubMed ID: 28109680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
    Gascón F; de la Fuente D; Puente J; Lozano J
    Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of generic drug supply in France].
    Taboulet F; Haramburu F; Latry P
    Rev Epidemiol Sante Publique; 2003 Sep; 51(4):415-25. PubMed ID: 13679734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International experiences of promoting generics use and its implications to China.
    Sun J
    J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generics: essentially similar, bioequivalent but not identical].
    Even-Adin D; De Muylder JA; Sternon J
    Rev Med Brux; 2001 Dec; 22(6):513-20. PubMed ID: 11811047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greek students' attitudes, perception and knowledge regarding generic medicines in times of economic crisis: a cross-sectional study.
    Domeyer PJ; Katsari V; Sarafis P; Aletras V; Niakas D
    BMC Med Educ; 2018 Nov; 18(1):262. PubMed ID: 30442145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
    Kong Y
    Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacy customers' attitude to generics].
    Madsen S; Huse J; Roksvaag PO
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):792-3. PubMed ID: 12693117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
    Moïse P; Docteur E
    Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.